TAFAZZIN and Barth syndrome: While more research is needed to fully understand the contribution of TMEM65 levels to disease development, it is promising that in both the mouse model of BTHS and the BTHS patient fibroblast study described here, we observed increased TMEM65 levels following AAV-TAZ gene delivery that correspond well with various functional improvements [19,20].